Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

CYTOCIDAL EFFECT OF RIFAMYCIN DERIVATIVES ON ASCITES TUMOR CELLS: STUDIES WITH 125I-IODODEOXYURIDINE

Journal Article · · Cancer Letters
OSTI ID:1014065
We have previously reported the chemotherapeutic effect of rifamycin derivatives on an ascites tumor, using increased life span as a criterion. These derivatives inhibit (1) RNA-instructed DNA polymerase in crude viral extracts; (2) virus-induced transformation in tissue cultures; and (3) the growth of tumors in vivo. One rifamycin derivative, rifazone-8{sub 2} (R-8{sub 2}), not only inhibits transformation in chick fibroblasts but affects the growth of transformed cells. The present study demonstrates that rifampicin and R-8{sub 2} act as cytocidal (rather than cytostatic) agents against some ascites cell lines.
Research Organization:
Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA (US)
Sponsoring Organization:
Chemical Sciences Division
DOE Contract Number:
AC02-05CH11231
OSTI ID:
1014065
Report Number(s):
LBL-8115
Journal Information:
Cancer Letters, Journal Name: Cancer Letters
Country of Publication:
United States
Language:
English

Similar Records

Preferential inhibition of the growth of virus-transformed cells in culture by rifazone-8/sub 2/, a new rifamycin derivative
Journal Article · Fri May 31 20:00:00 EDT 1974 · Proc. Natl. Acad. Sci. U.S.A.; (United States) · OSTI ID:6438290

PREFERENTIAL INHIBITION OF THE GROWTH OF VIRUS-TRANSFORMED CELLS IN CULTURE BY RIFAZONE-82, A NEW RIFAMYCIN DERIVATIVE
Journal Article · Thu Mar 28 00:00:00 EDT 1974 · Proceedings of the National Academy of Sciences · OSTI ID:939470

Inhibition of infectious Rous sarcoma virus production by a rifamycin derivative
Journal Article · Fri Apr 30 20:00:00 EDT 1976 · J. Virol.; (United States) · OSTI ID:7292954